Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2025-12-29 @ 12:24 AM
Study NCT ID:
NCT04551066
Status:
TERMINATED
Last Update Posted:
2025-10-21
First Post:
2020-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-25
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-11
First Submit QC Date:
None
Study First Post Date:
2020-09-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-10
Results First Submit QC Date:
None
Results First Post Date:
2024-10-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-06
Last Update Post Date:
2025-10-21
Last Update Post Date Type:
ESTIMATED